Literature DB >> 12391056

Low levels of nitric oxide and carbon monoxide in alpha 1-antitrypsin deficiency.

Roberto F Machado1, James K Stoller, Daniel Laskowski, Shuo Zheng, Joseph A Lupica, Raed A Dweik, Serpil C Erzurum.   

Abstract

Quantitations of exhaled nitric oxide (NO) and carbon monoxide (CO) have been proposed as noninvasive markers of airway inflammation. We hypothesized that exhaled CO is increased in individuals with alpha(1)-antitrypsin (AT) deficiency, who have lung inflammation and injury related to oxidative and proteolytic processes. Nineteen individuals with alpha(1)-AT deficiency, 22 healthy controls, and 12 patients with non-alpha(1)-AT-deficient chronic obstructive pulmonary disease (COPD) had NO, CO, CO(2), and O(2) measured in exhaled breath. Individuals with alpha(1)-AT deficiency had lower levels of NO and CO than control or COPD individuals. Alpha(1)-AT-deficient and COPD patients had lower exhaled CO(2) than controls, although only alpha(1)-AT-deficient patients had higher exhaled O(2) than healthy controls. NO was correlated inversely with exhaled O(2) and directly with exhaled CO(2), supporting a role for NO in regulation of gas exchange. Exhaled gases were not significantly related to corticosteroid use or lung function. Demonstration of lower than normal CO and NO levels may be useful as an additional noninvasive method to evaluate alpha(1)-AT deficiency in individuals with a severe, early onset of obstructive lung disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391056     DOI: 10.1152/japplphysiol.00659.2002

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  4 in total

1.  Detection of lung cancer by sensor array analyses of exhaled breath.

Authors:  Roberto F Machado; Daniel Laskowski; Olivia Deffenderfer; Timothy Burch; Shuo Zheng; Peter J Mazzone; Tarek Mekhail; Constance Jennings; James K Stoller; Jacqueline Pyle; Jennifer Duncan; Raed A Dweik; Serpil C Erzurum
Journal:  Am J Respir Crit Care Med       Date:  2005-03-04       Impact factor: 21.405

2.  Applied breath analysis: an overview of the challenges and opportunities in developing and testing sensor technology for human health monitoring in aerospace and clinical applications.

Authors:  Gary W Hunter; Raed A Dweik
Journal:  J Breath Res       Date:  2008-09       Impact factor: 3.262

Review 3.  Carbon monoxide in exhaled breath testing and therapeutics.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

Review 4.  Exhaled nitric oxide as a biomarker in COPD and related comorbidities.

Authors:  Mario Malerba; Alessandro Radaeli; Alessia Olivini; Giovanni Damiani; Beatrice Ragnoli; Paolo Montuschi; Fabio L M Ricciardolo
Journal:  Biomed Res Int       Date:  2014-02-27       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.